Glenmark settles patent suit with Nycomed

| Updated on: May 06, 2011

Glenmark Pharmaceuticals said on Friday that its subsidiary Glenmark Generics has entered into a settlement and licence agreement with US-based Nycomed to resolve patent infringement lawsuit for fluticasone propionate lotion, used for treating skin pain and itch.

“Glenmark Generics Ltd has entered into a settlement and licence agreement with Nycomed US to resolve the patent infringement suit regarding Glenmark's abbreviated new drug application for Fluticasone Propionate 0.05 lotion,” Glenmark said in a filing to the Bombay stock Exchange.

“Under the terms of agreement, Glenmark will be able to market and distribute its Fluticasone Propionate lotion under a royalty-bearing license from Nycomed US in March 2012, or earlier in certain circumstances,” it added.

Published on May 06, 2011

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you